Presentation is loading. Please wait.

Presentation is loading. Please wait.

Volume 64, Issue 6, Pages (December 2003)

Similar presentations


Presentation on theme: "Volume 64, Issue 6, Pages (December 2003)"— Presentation transcript:

1 Volume 64, Issue 6, Pages 2291-2297 (December 2003)
Plasma concentration of coupling factor 6 and cardiovascular events in patients with end-stage renal disease  Tomohiro Osanai, Masayuki Nakamura, Satoko Sasaki, Hirofumi Tomita, Masayuki Saitoh, Hiroshi Osawa, Hideaki Yamabe, Shuichi Murakami, Koji Magota, K.E.N. Okumura  Kidney International  Volume 64, Issue 6, Pages (December 2003) DOI: /j x Copyright © 2003 International Society of Nephrology Terms and Conditions

2 Figure 1 Relationship between plasma coupling factor 6 (CF6) level and serum creatinine concentration in patients with end-stage renal disease (ESRD). Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions

3 Figure 2 Relationship between plasma coupling factor 6 (CF6) level and cardiovascular events in patients with end-stage renal disease (ESRD). Abbreviations are: IHD, ischemic heart disease (myocardial infarction plus angina); CHF, congestive heart failure. Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions

4 Figure 3 Relationship between plasma asymmetric dimethylarginine (ADMA) level and duration of dialysis treatment (month) in patients with end-stage renal disease (ESRD). Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions

5 Figure 4 Relationship between plasma asymmetric dimethylarginine (ADMA) level and cardiovascular events in patients with end-stage renal disease (ESRD). Abbreviations are: IHD, ischemic heart disease (myocardial infarction plus angina); CHF, congestive heart failure. Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions

6 Figure 5 Relationship between plasma coupling factor 6 (CF6) level and plasma asymmetric dimethylarginine (ADMA) level in patients with end-stage renal disease (ESRD). Kidney International  , DOI: ( /j x) Copyright © 2003 International Society of Nephrology Terms and Conditions


Download ppt "Volume 64, Issue 6, Pages (December 2003)"

Similar presentations


Ads by Google